MENU
+Compare
VRAX
Stock ticker: NASDAQ
AS OF
Sep 12 closing price
Price
$0.60
Change
+$0.02 (+3.45%)
Capitalization
2.59M

VRAX Virax Biolabs Group Limited Forecast, Technical & Fundamental Analysis

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats... Show more

VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VRAX with price predictions
Sep 12, 2025

VRAX in upward trend: price may jump up because it broke its lower Bollinger Band on August 26, 2025

VRAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 22 cases where VRAX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VRAX's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 44 cases where VRAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VRAX just turned positive on September 12, 2025. Looking at past instances where VRAX's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRAX advanced for three days, in of 130 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VRAX as a result. In of 54 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for VRAX crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VRAX entered a downward trend on September 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.454) is normal, around the industry mean (20.524). P/E Ratio (0.000) is within average values for comparable stocks, (53.276). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.172). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (357.143) is also within normal values, averaging (337.274).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VRAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VRAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
20 North Audley Street
Phone
+44 2077887414
Employees
11
Web
https://www.viraxbiolabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMEC1.870.06
+3.31%
Primech Holdings Ltd
MOS33.65-0.03
-0.09%
Mosaic Company (The)
OFG43.76-0.39
-0.88%
OFG Bancorp
KRNY6.56-0.14
-2.09%
Kearny Financial Corp
BINI0.07-0.01
-17.15%
Bollinger Innovations Inc

VRAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+2.76%
ALZN - VRAX
45%
Loosely correlated
+0.42%
NTRB - VRAX
31%
Poorly correlated
+3.17%
PTGX - VRAX
30%
Poorly correlated
-1.37%
PYPD - VRAX
28%
Poorly correlated
+0.58%
CUE - VRAX
27%
Poorly correlated
-3.16%
More